Skip to content

Public FDA record

Z-2761-2019: Cascade Abrazo aPTT Test Card, Model 5722, For Export Only. The firm name on the label is Helena Laborat

Recall record Z-2761-2019 for Helena Laboratories, Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2761-2019
Company in FDA record
Helena Laboratories, Corp.
FDA classification date
Sep 27, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Some of the cards show occasional shorter clot times than the expected variation resulting in a potential false negative result on the screening assay.

Source facts

Action
The recalling firm issued letters dated 11/12/2017 via email on 12/7/2017 explaining the issue and that they were doing a withdrawal of the lot.
Initiated
2017-12-07
Root cause
Unknown/Undetermined by firm
Terminated
2020-06-09
Distribution
Distribution was made to Germany and Australia. There was no U.S. distribution.
Recall number
Z-2761-2019
Recall status
Terminated
CDRH record ID
175967
FDA classified
2019-09-27
Recall event number
83629

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗